Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Baliopharm AG

Baliopharm AG is a biotechnology company focusing on the development of novel antibody-based therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. Baliopharm’s antibody pipeline consisting of two selective TNF-R1 antagonists, Atrosab and Atrosimab and the bispecific anti-CD20/CD95 antibody construct, Novotarg. Baliopharm was founded in 2011 as a spin-off of Celonic AG, an internationally operating service provider in the area of contract development and manufacturing of biopharmaceuticals operating since 1998. Baliopharm AG is located in Basel (Switzerland). *

 

Period Start 2011-01-01 splitoff
  Group Promethera (Group)
  Predecessor Celonic AG
Products Industry therapeutic protein
  Industry 2 Atrosab
Person Person Herrmann, Andreas (Valerius Biopharma 201805 CEO + Founder before Alvotech + Celonic + Baliopharm + Synimmune + Cardion)
     
Region Region Basel BS
  Country Switzerland
  Street 55 Eulerstr.
  City 4051 Basel
  Tel +41-61-2053-910
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Promethera Biosciences S.A.. (4/10/18). "Press Release: Promethera Biosciences Acquires Baliopharm AG to Strengthen its Therapeutic Strategy in NASH With a Unique Tumor Necrosis Factor Receptor 1 (TNF-R1) Antibody Drug Candidates". Mont-Saint-Guibert & B
     
   
Record changed: 2018-09-29

Advertisement

Picture [iito] Männer Ballett 650x80px

More documents for Promethera (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] No Content Marketing 650x80px




» top